Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19
Xin Hu(Discovery Institute), Min Shen(Kaili University), Jonathan H. Shrimp(National Institutes of Health), Anton Simeonov(National Institutes of Health), Alexey Zakharov(Imperial College London), Sankalp Jain(National Institutes of Health), Miao Xu(National Center for Advancing Translational Sciences), Wei Zhu(Shanghai Tenth People's Hospital), Hui Guo(First Affiliated Hospital of Xi'an Jiaotong University), Catherine Z. Chen(National Institutes of Health), Paul Shinn(National Institutes of Health), Matthew D. Hall(National Institutes of Health)
Cited by 56
Related Papers
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
|Cell|2020|802
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
|Nature Medicine|2016|570
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
|Cell stem cell|2020|460
Unexplored therapeutic opportunities in the human genome
|Nature Reviews Drug Discovery|2018|391
Erratum: Unexplored therapeutic opportunities in the human genome
|Nature Reviews Drug Discovery|2018|327